Pfizer vs Qualcomm: Founders, CEOs and History
Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla. Qualcomm was founded in 1985 by Irwin Jacobs, Andrew Viterbi and is led by Cristiano Amon.
Company facts
Founders
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
Qualcomm
Irwin Jacobs
Irwin Jacobs is an American electrical engineer who co-founded Qualcomm and was its first CEO. He had been a professor at UC San Diego and had co-founded Linkabit.
Andrew Viterbi
Andrew Viterbi brought the deepest technical credentials of Qualcomm's founding team, combining top academic training in communications theory with practical experience in defense and commercial digital systems.
CEOs and their tenures
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Qualcomm
- Steve Mollenkopf2013–2021
Chief Executive Officer
As CEO, he navigated the company through brutal antitrust litigation with Apple and the FTC, securing the critical 5G licensing agreements that stabilized Qualcomm's revenue model.
Source - Akash Palkhiwala2019–present
Chief Financial Officer and Chief Operating Officer
As CFO, he executed massive share repurchase programs and maintained strong gross margins despite extreme volatility in global smartphone demand.
Source - Cristiano Amon2021–present
President and Chief Executive Officer
Cristiano Amon, a Brazilian electrical engineer, joined Qualcomm in 1995 and led its QCT chip business and president role before becoming CEO on June 30, 2021, succeeding Steve Mollenkopf.
Source
Timeline: Pfizer and Qualcomm side by side
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1985Qualcomm
Qualcomm Founded
Irwin Jacobs, Andrew Viterbi, and five colleagues found Qualcomm Incorporated in San Diego, California, initially operating as a telecommunications consulting and research firm from a converted restaurant building.
1988Qualcomm
OmniTRACS Commercial Launch
Qualcomm commercially launches OmniTRACS, a satellite-based two-way messaging and positioning system for long-haul trucking that becomes the company's first profitable product and funds ongoing CDMA research.
1989Qualcomm
First Live CDMA Demonstration
Qualcomm conducts its first outdoor live CDMA demonstration in San Diego, proving the technology works in real-world conditions and attracting serious attention from U.S. Cellular carriers and equipment manufacturers.
1991Qualcomm
Initial Public Offering
Qualcomm goes public on the Nasdaq Stock Market in December 1991, raising approximately $43 million at $16 per share in an IPO that gives the company capital to accelerate CDMA commercialization.
1993Qualcomm
IS-95 CDMA Standard Adopted
The Telecommunications Industry Association formally adopts IS-95, a CDMA standard based substantially on Qualcomm's technology, as an approved digital cellular standard in the United States validating the company's decade-long technological bet.
1995Qualcomm
First Commercial CDMA Network Launched
Sprint PCS launches the first commercial CDMA cellular network in the United States, using Qualcomm-based technology and marking the beginning of large-scale commercial deployment that would define U.S. Wireless infrastructure for the next twenty years.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
1999Qualcomm
Strategic Exit from Infrastructure and Handsets
Qualcomm sells its network infrastructure division to Ericsson and its handset manufacturing business to Kyocera, focusing the company entirely on chip design and patent licensing a strategic concentration that defines its business model to the present day.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2007Qualcomm
Snapdragon Platform Introduction
Qualcomm introduces the Snapdragon brand for its mobile system-on-chip processors, establishing a consumer-facing identity for its mobile silicon that would become synonymous with premium Android smartphone performance over the following decade.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2019Qualcomm
Apple Settlement and Licensing Agreement
Following years of contentious litigation, Qualcomm and Apple reach a global settlement in April 2019 covering all pending litigation worldwide, with Apple agreeing to a multi-year chip supply deal and a licensing arrangement reportedly involving back payments…
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2021Qualcomm
Nuvia Acquisition
Qualcomm acquires Nuvia, a CPU startup founded by former Apple Silicon architects, for approximately $1.4 billion, bringing custom CPU design capabilities in-house that power the Oryon cores in Snapdragon 8 Elite and Snapdragon X Elite PC chips.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2023Qualcomm
Snapdragon X Elite PC Platform Launch
Qualcomm launches the Snapdragon X Elite and Snapdragon X Plus platforms for Windows PCs, powering Microsoft's Copilot+ PC initiative and marking the company's most significant push into personal computing since the failed Snapdragon 835 PC effort in 2017.
2024Qualcomm
Snapdragon 8 Elite Launch
Qualcomm launches the Snapdragon 8 Elite, its first phone chip with custom Oryon CPU cores, built on TSMC's 3nm process.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2025Qualcomm
Alphawave Semi Acquisition Completed
Qualcomm completes its roughly $2.4B purchase of Alphawave Semi to accelerate data center connectivity products.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
2026Qualcomm
Q2 FY2026 Results and $20B Buyback Authorization
Qualcomm reports Q2 FY2026 revenue of $10.599B, record quarterly QCT automotive revenue, 20% year-over-year growth in combined QCT automotive and IoT revenue, and a new $20B repurchase authorization.
2026Qualcomm
Q3 FY2026 Results and $40B Non-Handset Target
Qualcomm reports Q3 FY2026 revenue of $9.9B (down 4%), automotive revenue up 61% to $1.6B, and raises its FY2029 non-handset revenue target to $40B.
Acquisitions
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Qualcomm
- Modular2026$3.9B
- Alphawave Semi2025$2.4B
- Veoneer Active Safety (ADAS Division)2022$4.5B
- Nuvia2021$1.4B
- RF360 Holdings (joint venture buyout)2019Undisclosed
- Atheros Communications2011$3.1B
Questions about Pfizer vs Qualcomm
Who is the CEO of Pfizer Inc. and Qualcomm Inc.?
Pfizer Inc. is led by Albert Bourla and Qualcomm Inc. is led by Cristiano Amon. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Pfizer Inc. founded vs Qualcomm Inc.?
Pfizer Inc. was founded in 1849 — 136 years before Qualcomm Inc., which was founded in 1985. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Qualcomm Inc..
How many employees does Pfizer Inc. have compared to Qualcomm Inc.?
Pfizer Inc. employs approximately 75,000 people, while Qualcomm Inc. employs approximately 52,000. Pfizer Inc. has the larger workforce at 75,000 employees, compared to Qualcomm Inc.'s 52,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Pfizer Inc. and Qualcomm Inc. headquartered?
Both Pfizer Inc. and Qualcomm Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Pfizer Inc. and Qualcomm Inc.?
Pfizer Inc. was founded by Charles Pfizer, Charles Erhart. Qualcomm Inc. was founded by Irwin Jacobs, Andrew Viterbi.
Which company has a longer operating history — Pfizer Inc. or Qualcomm Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. Qualcomm Inc. has been in operation for around 41 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Pfizer vs Qualcomm overview